FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for concealment as EMA, Canada already updated labels., US News, Times Now ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined oral contraceptives, intrauterine devices, progestin-only pills, or subdermal ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

Evidence indicates that Depo-Provera can cause specific mutations in women's DNA. Given the availability of alternatives without this known risk, the continued use of the shot difficult to justify.” — ...

The MarketWatch News Department was not involved in the creation of this content. The number of lawsuits filed has tripled to over 1300 since May New US peer-reviewed study adds to body of research ...

THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...

The MarketWatch News Department was not involved in the creation of this content. -- Global pharmaceutical company Pfizer Inc. is facing a multidistrict litigation (MDL No.3140) in the USA, currently ...